Results 71 to 80 of about 416,781 (292)
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective In multiple sclerosis, the optimal time for deploying a therapeutic intervention is before the central nervous system is damaged; given the success of trials treating the earliest stage of MS, the radiologically isolated syndrome, developing primary prevention strategies is an important next challenge.
Amy W. Laitinen +7 more
wiley +1 more source
ROCS: receiver operating characteristic surface for class-skewed high-throughput data. [PDF]
PLoS ONE, 2012 The receiver operating characteristic (ROC) curve is an important tool to gauge the performance of classifiers. In certain situations of high-throughput data analysis, the data is heavily class-skewed, i.e.
Tianwei Yu
doaj +1 more source
Location‐Specific Hematoma Volume Predicts Early Neurological Deterioration in Supratentorial ICH
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Early neurological deterioration (END) adversely affects outcomes in patients with intracerebral hemorrhage (ICH). This study aimed to determine the location‐specific hematoma volumes for END in supratentorial ICH patients. Methods We retrospectively analyzed supratentorial ICH patients presenting from two prospective cohorts.
Zuoqiao Li +10 more
wiley +1 more source
Review on ROC Curves in the Presence of Covariates
Revstat Statistical Journal, 2013 REVSTAT-Statistical Journal, Vol. 12 No.
Pardo Fernández, Juan Carlos +2 more
openaire +5 more sources
COMPARING DIAGNOSTIC TESTS FROM ROC CURVE COMPARACIÓN DE PRUEBAS DIAGNÓSTICAS DESDE LA CURVA ROC
Revista Colombiana de Estadística, 2007 We study the problem of comparing the power of classification of different methods from the ROC Curve. On one hand, we propose a method based on the supremum measure and, on the other hand, we study the problem of comparing two or more ROC curves from ...
Martínez-Camblor Pablo
doaj
Clinical Validation of Plasma p‐217tau in Neurological Diseases
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Plasma p‐217tau is a minimally invasive but specific biomarker for diagnosing Alzheimer's disease (AD). However, its disease specificity remains to be clinically evaluated. We validated the reliability of the p‐217tau biomarker in 12 other neurological diseases.
Takeshi Kawarabayashi +13 more
wiley +1 more source
Emergency Medicine Journal, 2017 The paper by Bodyet alis concerned with the evaluation of decision aids, which can be used to identify potential acute coronary syndromes (ACS) in the ED. The authors previously developed the Manchester Acute Coronary Syndromes model (MACS) decision aid, which uses several clinical variables and two biomarkers to ‘rule in’ and ‘rule out’ ACS.
Hoo, Z.H., Candlish, J., Teare, M.D.
openaire +3 more sources
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective To assess the association and discriminative performance of serum biomarkers with clinical disease progression and survival in patients with amyotrophic lateral sclerosis (ALS). Methods This retrospective study, conducted at Houston Methodist Hospital, Houston, TX, used longitudinal serum samples collected between January 2018 and ...
David R. Beers +7 more
wiley +1 more source